Statistical Treatment and Tables_SPC Research

Embed Size (px)

Citation preview

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    1/27

    Group Type of Card PHARMACY BRANCH Gender Age

    1 With reward One Fai!y Ma!e "#

    $ With reward One Fai!y Fea!e $%

    # With reward One Fai!y Ma!e #1

    % With reward One Fai!y Ma!e $&

    ' With reward One Fai!y Fea!e #$

    " With reward One Fai!y Fea!e $(( With reward One Fai!y Fea!e $1

    ) With reward One Fai!y Ma!e ')

    & With reward One Fai!y Fea!e #(

    1* With reward One Fai!y Ma!e 1&

    11 With reward One Fai!y Fea!e %&

    1$ With reward One Fai!y Ma!e "%

    1# With reward One Fai!y Fea!e %*

    1% With reward One Fai!y Fea!e 1)

    1' With reward One Fai!y Fea!e "#

    1" With reward +u,re! Ma!e $&1( With reward +u,re! Fea!e $1

    1) With reward +u,re! Fea!e "$

    1& With reward +u,re! Ma!e $%

    $* With reward +u,re! Fea!e $"

    $1 With reward +u,re! Fea!e #*

    $$ With reward +u,re! Fea!e $(

    $# With reward +u,re! Fea!e '$

    $% With reward +u,re! Fea!e %"

    $' With reward +u,re! Fea!e '#

    $" With reward +u,re! Fea!e '*

    $( With reward +u,re! Fea!e $&

    $) With reward +u,re! Ma!e #"

    $& With reward +u,re! Ma!e #1

    #* With reward +u,re! Ma!e $'

    1 Without reward Boti-a Hanoi Fea!e $"

    $ Without reward Boti-a Hanoi Fea!e $)

    # Without reward Boti-a Hanoi Fea!e $%

    % Without reward Boti-a Hanoi Ma!e $&

    ' Without reward Boti-a Hanoi Fea!e '&

    " Without reward Boti-a Hanoi Fea!e 1)

    ( Without reward Boti-a Hanoi Fea!e $1

    ) Without reward Boti-a Hanoi Fea!e $)

    & Without reward Boti-a Hanoi Fea!e $(

    1* Without reward Boti-a Hanoi Fea!e $"

    11 Without reward Boti-a Hanoi Ma!e "*

    1$ Without reward Boti-a Hanoi Ma!e %)

    1# Without reward Boti-a Hanoi Ma!e $&

    1% Without reward Boti-a Hanoi Fea!e $'

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    2/27

    1' Without reward Boti-a Hanoi Fea!e '(

    1" Without reward Beu.ie Ma!e $"

    1( Without reward Beu.ie Fea!e #&

    1) Without reward Beu.ie Fea!e #%

    1& Without reward Beu.ie Ma!e $(

    $* Without reward Beu.ie Fea!e $$

    $1 Without reward Beu.ie Fea!e ##$$ Without reward Beu.ie Ma!e "1

    $# Without reward Beu.ie Fea!e ")

    $% Without reward Beu.ie Fea!e 1&

    $' Without reward Beu.ie Fea!e '%

    $" Without reward Beu.ie Fea!e $%

    $( Without reward Beu.ie Fea!e %(

    $) Without reward Beu.ie Fea!e $)

    $& Without reward Beu.ie Fea!e #*

    #* Without reward Beu.ie Ma!e $"

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    3/27

    Pre/0a!e Pot2a!e Pre2tore.iit Pot2tore Preyo Carditt

    $%13'* ''#3** ' 1* 1 *

    &'#3%* 14(*&3** 1) #* 1 *

    1$*3$* ""13** $ 1* 1 *

    #1(3$* )##3** % 1* 1 *

    )(13## 14#"%3(' 1% $* 1 *

    14$"(3"( $4*)13'* $* #* 1 * 14''(3)( $4$%$3** $# #* 1 *

    #113*% (&%3'* ' 1$ 1 *

    ''3** 11)3** 1 $ 1 *

    )1'3$' 14$$(3** 1' $* 1 *

    &1(3$' 14"*)3(' 1$ $* 1 *

    "%%3(* &"13** ( 1* 1 *

    14')#3## $4')'3** $* #* 1 *

    #1#3'% )1$3'* ' 1$ 1 *

    14*#13$' 14%''3** 1' $* 1 *

    14#()3)* $4%%)3** 1) #* 1 * 14#%*3** $4*($3** $* $& 1 *

    $')3"( %#*3** % " 1 *

    1(%3"* "$$3** # 1* 1 *

    14*"(3(# 14($*3** 1' $$ 1 *

    ($(3$* 14#1$3** 1$ $* 1 *

    14*&'3** 14&('3** 1' $' 1 *

    #*13"( (&"3** ' 1$ 1 *

    14#')3"( $4$%)3** $* #* 1 *

    14(**3"( $4("13** $* #* 1 *

    14")13"* $4$'$3** $% #* 1 *

    "'(3'* 14#&'3** 1* $* 1 *

    #1131' ))(3** ' 1# 1 *

    #'*3** ("*3** ' 1* 1 *

    ##$3*) ))13** ' 1$ 1 *

    "&)3** "&*3** ) 11 * 1

    ##%3** #$%3** ' " * 1

    "%13** "$'3** ) 1* * 1

    '$$3** )##3** ' 1* * 1

    )1*3** )**3** 1* 1$ * 1

    14$'"3** 14$$)3** 1% 1" * 1

    ''$3** '%(3** ' ( * 1

    )113** )*$3** & 11 * 1

    ##(3** ##$3** ' ' * 1

    )1"3** )*"3** 1* 11 * 1

    )%13** )$"3** 1' 1% * 1

    )(&3** )'&3** 1* 1* * 1

    %"*3** %'*3** ' " * 1

    "*$3** ')$3** 1* ) * 1

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    4/27

    $%#3** $##3** ' % * 1

    14##%3** 14#&%3** $* $* * 1

    14$$%3** 14$()3** 1) $$ * 1

    141**3** 141&*3** 1) $$ * 1

    14%)#3** 14')#3** $' #* * 1

    14$&(3** 14#((3** $* $* * 1

    14"#13** 14"&13** $* $" * 1 14#"(3** 14%*(3** $* $# * 1

    14%1"3** 14%&"3** $* $% * 1

    14$''3** 14$(#3** 1) $* * 1

    14(")3** 14)")3** $' #* * 1

    14&)$3** $4*$)3** $# #* * 1

    $"13** $)13** ' ' * 1

    14##&3** 14%113** 1) $* * 1

    14"*"3** 14"'"3** $' #* * 1

    "#(3** "'$3** ' 1* * 1

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    5/27

    51 5$ 5#A 5#B 5#C 5#6

    1 * * * * 1

    * * * * * 1

    1 1 * * * *

    1 * * * 1 *

    1 1 * * * *

    1 1 * * * ** 1 * * * 1

    * 1 * 1 1 1

    1 * * * * 1

    1 1 * * * *

    1 1 * * * *

    1 1 * * * *

    * * * * * 1

    * * * * * 1

    1 1 * * * *

    1 1 * * * *1 1 * * * *

    1 1 * * * *

    1 1 * * * *

    1 1 * * * *

    1 1 * * * *

    1 1 * * * *

    1 1 * * * *

    1 1 * * * *

    1 1 * * * *

    * * * 1 * *

    1 1 * * * *

    1 1 * * * *

    1 1 * * * *

    * * * 1 * *

    * * * * * 1

    * * * * * 1

    * * * * * 1

    1 * * * * 1

    * * 1 1 1 *

    * * * * * 1

    * * * * * 1

    * * * * * 1

    * * * * * 1

    * * * * * 1

    * * * * * 1

    * * * * * 1

    * * 1 * * 1

    * * * * * 1

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    6/27

    * * 1 * * 1

    * * * * * 1

    * * * * * 1

    1 1 * * * *

    1 1 * * * *

    * * * * * *

    1 * * * 1 ** * * * * *

    1 * * 1 * 1

    * * * * * *

    * * 1 1 1 1

    * * 1 * * 1

    1 1 * * * *

    * * * * * 1

    * * * * * 1

    * * 1 * * *

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    7/27

    Group Pre Pot

    1 ' 1*

    1 1) #*

    1 $ 1*

    1 % 1*1 1% $*

    1 $* #*

    1 $# #*

    1 ' 1$

    1 1 $

    1 1' $*

    1 1$ $*

    1 ( 1*

    1 $* #*

    1 ' 1$1 1' $*

    1 1) #*

    1 $* $&

    1 % "

    1 # 1*

    1 1' $$

    1 1$ $*

    1 1' $'

    1 ' 1$

    1 $* #*

    1 $* #*

    1 $% #*

    1 1* $*

    1 ' 1#

    1 ' 1*

    1 ' 1$

    $ ) 11

    $ ' "

    $ ) 1*

    $ ' 1*

    $ 1* 1$

    $ 1% 1"

    $ ' (

    $ & 11

    $ ' '

    $ 1* 11

    $ 1' 1%

    $ 1* 1*

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    8/27

    $ ' "

    $ 1* )

    $ ' %

    $ $* $*

    $ 1) $$

    $ 1) $$

    $ $' #*$ $* $*

    $ $* $"

    $ $* $#

    $ $* $%

    $ 1) $*

    $ $' #*

    $ $# #*

    $ ' '

    $ 1) $*

    $ $' #*$ ' 1*

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    9/27

    Pre Tet Pot Tet

    Contro! Treatent Contro! Treatent

    Count #* #* #* #*

    Mean 1#3%( 113'( 1'3(( 1)3)#

    0tandard 6e.iation (31( (31) )3'1 )3)&Ma7iu $'3** $%3** #*3** #*3**

    5# $*3** 1)3** $$3** $&3('

    Median 1$3** 1$3** 1#3** $*3**

    51 '3(' '3** 1*3** 1*3'*

    Miniu '3** 13** %3** $3**

    Contro! Treatent Contro! Treatent

    Botto '3(' '3** 1*3** 1*3'*

    $5Bo7 "3$' (3** #3** &3'*

    #58o7 )3** "3** &3** &3('Whi9er / *3(' %3** "3** )3'*

    Whi9er : '3** "3** )3** *3$'

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    10/27

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    11/27

    Group Pre Pot

    1 $%13'* ''#3**

    1 &'#3%* 14(*&3**

    1 1$*3$* ""13**

    1 #1(3$* )##3**1 )(13## 14#"%3('

    1 14$"(3"( $4*)13'*

    1 14''(3)( $4$%$3**

    1 #113*% (&%3'*

    1 ''3** 11)3**

    1 )1'3$' 14$$(3**

    1 &1(3$' 14"*)3('

    1 "%%3(* &"13**

    1 14')#3## $4')'3**

    1 #1#3'% )1$3'*1 14*#13$' 14%''3**

    1 14#()3)* $4%%)3**

    1 14#%*3** $4*($3**

    1 $')3"( %#*3**

    1 1(%3"* "$$3**

    1 14*"(3(# 14($*3**

    1 ($(3$* 14#1$3**

    1 14*&'3** 14&('3**

    1 #*13"( (&"3**

    1 14#')3"( $4$%)3**

    1 14(**3"( $4("13**

    1 14")13"* $4$'$3**

    1 "'(3'* 14#&'3**

    1 #1131' ))(3**

    1 #'*3** ("*3**

    1 ##$3*) ))13**

    $ "&)3** "&*3**

    $ ##%3** #$%3**

    $ "%13** "$'3**

    $ '$$3** )##3**

    $ )1*3** )**3**

    $ 14$'"3** 14$$)3**

    $ ''$3** '%(3**

    $ )113** )*$3**

    $ ##(3** ##$3**

    $ )1"3** )*"3**

    $ )%13** )$"3**

    $ )(&3** )'&3**

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    12/27

    $ %"*3** %'*3**

    $ "*$3** ')$3**

    $ $%#3** $##3**

    $ 14##%3** 14#&%3**

    $ 14$$%3** 14$()3**

    $ 141**3** 141&*3**

    $ 14%)#3** 14')#3**$ 14$&(3** 14#((3**

    $ 14"#13** 14"&13**

    $ 14#"(3** 14%*(3**

    $ 14%1"3** 14%&"3**

    $ 14$''3** 14$(#3**

    $ 14(")3** 14)")3**

    $ 14&)$3** $4*$)3**

    $ $"13** $)13**

    $ 14##&3** 14%113**

    $ 14"*"3** 14"'"3**$ "#(3** "'$3**

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    13/27

    Pre Tet Pot Tet

    Contro! Treatent Contro! Treatent

    Count #* #* #* #*

    Mean &)#3%* (&13$* 1*1(3%* 1#)'3'*

    0tandard 6e.iation %)13&( '$*3)% '*'3'* (1&3"%Ma7iu 1&)$3** 1(**3"( $*$)3** $("13**

    5# 1##(3(' 1$$%3'* 1%*#3(' $*%(3('

    Median )"*3** ((13$# )%"3** 1##)3#)

    51 "1*3(' #113(' "#13(' )**31#

    Miniu $%#3** ''3** $##3** 11)3**

    Contro! Treatent Contro! Treatent

    Botto "1*3(' #113(' "#13(' )**31#

    $5Bo7 $%&3$' %'&3%( $1%3$' '#)3$'

    #58o7 %((3(' %'#3$) ''(3(' (*&3#)Whi9er / #"(3(' $'"3(' #&)3(' ")$31#

    Whi9er : "%%3$' %("31( "$%3$' (1#3$'

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    14/27

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    15/27

    6ata

    Gender A.erage / Pre2tore.iit A.erage / Pot2tore.iitFea!e 1#3&'1$1&'1$$ 1)3(#1(*(#1(1Ma!e &3%$1*'$"#1" 1%3$1*'$"#1')

    Total Result 12.5166666667 17.3

    Gender / a!! /

    6ataAge A.erage / Pre2tore.iit A.erage / Pot2tore.iit1)/$( 1#3%()$"*)"&" 1)31(#&1#*%#'

    $)/#( 1*3#'$&%11("' 1'3"%(*'))$#'

    #)/%( 1'3(' $13('%)/'( 1%3%$)'(1%$)" 1&3%$)'(1%$)"')/") 113$$$$$$$$$$ 1%3'''''''''"

    Total Result 12.5166666667 17.3

    6ataType of Card A.erage / Pre2tore.iit A.erage / Pot2tore.iit

    With reward 113'""""""""( 1)3)#########Without reward 1#3%""""""""( 1'3(""""""""(

    Total Result 12.5166666667 17.3

    6ataPHARMACY BRA A.erage / Pre2tore.iit A.erage / Pot2tore.iitBeu.ie 1)3"""""""""( $$31#########

    Boti-a Hanoi )3$""""""""( &3%

    +u,re! 1$3*""""""""( 1&3########One Fai!y 113*""""""""( 1(3(#########

    Total Result 12.5166666667 17.3

    Fee! -oforta8!e 8uying at thi phara-y6ata

    5#6 A.erage / Pre2tore.iit A.erage / Pot2tore.iit

    * 1$3)%#(' 1)3&")('

    1 1$31%$)'(1%$& 1'3#&$)'(1%$&

    ;i.e near the area

    6ata5#A A.erage / Pre2tore.iit A.erage / Pot2tore.iit* 1$3'''''''''" 1(3'1)'1)'1)'

    1 1$31""""""""( 1'3##########

    Pri-e are -heaper

    6ata5#B A.erage / Pre2tore.iit A.erage / Pot2tore.iit* 1$3$'&$'&$' 1(

    1 1%3)######### $*

    -!oe re!ationhip with the Phara-it < a!e ta=

    6ata5#C A.erage / Pre2tore.iit A.erage / Pot2tore.iit

    * 1$3%&*&*&*&*& 1(3$#"#"#"#"%

    1 1$3) 1)

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    16/27

    6ata

    Gender A.erage / Pre/0a!e A.erage / Pot2a!eFea!e 14#*#3(&Ma!e "')3&$ &)*3"1

    Total Result 887.30 1,201.45

    Gender / a!! /

    6ataAge A.erage / Pre/0a!e A.erage / Pot2a!e1)/$( &%)31% 14$#(3#'

    $)/#( (%*3"( 14*""3)1

    #)/%( 141*"3(' 14'&)3**%)/'( 14*(*31( 14%)$3'%')/") ("&3*$ &"&31(

    Total Result 887.30 1,201.45

    6ataType of Card A.erage / Pre/0a!e A.erage / Pot2a!e

    With reward (&13$* 14#)'3'*Without reward &)#3%* 14*1(3%*

    Total Result 887.30 1,201.45

    6ataPHARMACY BRA A.erage / Pre/0a!e A.erage / Pot2a!eBeu.ie 14#1#3## 14#($3##

    Boti-a Hanoi "'#3%( ""$3%(

    +u,re! )%&3*$ 14'*#3One Fai!y (##3#( 14$"(3*(

    Total Result 887.30 1,201.45

    Fee! -oforta8!e 8uying at thi phara-y6ata

    5#6 A.erage / Pre/0a!e A.erage / Pot2a!e

    * )&$3'% 14#%#3&1

    1 ))13#1 14*#)3"%

    ;i.e near the area

    6ata5#A A.erage / Pre/0a!e A.erage / Pot2a!e* )("3"# 14$$#3$"

    1 &)#3## 14**'31(

    Pri-e are -heaper

    6ata5#B A.erage / Pre/0a!e A.erage / Pot2a!e* )")3)( 141)'31*

    1 14*'#31$ 14#%)3')

    -!oe re!ationhip with the Phara-it < a!e ta=

    6ata5#C A.erage / Pre/0a!e A.erage / Pot2a!e

    * ))*3*1 14$*13)#

    1 &"(3%' 141&(3#*

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    17/27

    Ano.a> Two/Fa-tor With Rep!i-ation

    0?MMARY Pre Pot Tota!

    1

    Count #* #* "*

    0u #%( '"' &1$

    A.erage 113'""""( 1)3)#### 1'3$@arian-e '13%&'%*$ (&31*&$ ((3"$*#%

    2

    Count #* #* "*

    0u %*% %(# )((

    A.erage 1#3%""""( 1'3("""( 1%3"1""(

    @arian-e '13#"*&$ ($3%"*&$ "$3$*"'

    Total

    Count "* "*0u ('1 1*#)

    A.erage 1$3'1"""( 1(3#

    @arian-e '13%(%$&% ("3)&1'#

    ANO@A

    Source of Variation SS df MS F

    Group Treatent / Contro! 1*3$1 1 1*3$1 *31"

    Change Pre/Pot ")"3%1 1 ")"3%1 1*3(&

    ntera-tion 1)'3*1 1 1)'3*1 $3&1Within (4#()3#( 11" "#3"1

    Tota! )4$'&3&& 11&

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    18/27

    Pre Pot

    Treatent 113" 1)3)

    Contro! 1#3' 1'3)

    P-value F crit

    *3"& #3&$

    *3** #3&$

    *3*& #3&$

    Pre*3*

    '3*

    1*3*

    1'3*

    $*3*

    Average store visits, Treatment vs Control Grou

    Treatent Contro!

    Contro! Treatent

    *3**

    '3**

    1*3**

    1'3**

    $*3**

    $'3**

    #*3**

    #'3**

    re!e"periment #tore $isits

    %o. o& $isits

    Contro! Treatent

    *3**

    '3**

    1*3**

    1'3**

    $*3**

    $'3**

    #*3**

    #'3**

    ost!e"periment #tore $isits

    %o. o& visits

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    19/27

    Pot

    ps

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    20/27

    Ano.a> Two/Fa-tor With Rep!i-ation

    0?MMARY Pre Pot Tota!

    1

    Count #* #* "*

    0u $#4(#'3)" %14'"'3** "'4#**3)"

    A.erage (&13$* 14#)'3'* 14*))3#'@arian-e $(14$"&3#" '1(4)))3"* %((4")(3#'

    2

    Count #* #* "*

    0u $&4'*$3** #*4'$$3** "*4*$%3**

    A.erage &)#3%* 14*1(3%* 14***3%*

    @arian-e $#$4$&&31% $''4'$"3)* $%*4*($3('

    Total

    Count "* "*0u '#$#(3)'"11))) ($*)(

    A.erage ))(3$&("*1&)1% 1$*13%'

    @arian-e $'"&*)3$$%$' %1%"*13)("(

    ANO@A

    Source of Variation SS df MS

    0ap!e $#$4*%#3%$ 1 $#$4*%#3%$

    Co!un $4&"*4('13)) 1 $4&"*4('13))

    ntera-tion $4#'%4'"*3&) 1 $4#'%4'"*3&)Within #(4*#$4'##3#$ 11" #1&4$%'3&)

    Tota! %$4'(&4))&3"* 11&

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    21/27

    PreTet PotTet

    Treatent (&131&'$ 1#)'3'

    Contro! &)#3% 1*1(3%

    F P-value F crit

    *3($( *3#&" #3&$#

    &3$(% *3**# #3&$#

    (3#(' *3**) #3&$#

    PreTet*

    $**

    %**

    "**

    )**

    1***

    1$**

    1%**

    1"**

    Average pur'(ases, Treatment vs Co

    Treatent Co

    Contro!

    *3**

    $**3**

    %**3**

    "**3**

    )**3**

    1***3**

    1$**3**

    1%**3**

    1"**3**

    re!e"periment ur'(ases per re

    #ales

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    22/27

    PotTet

    ntrol Groups

    ntro!

    Treatent

    pon)ent

    Contro!

    *3**

    '**3**

    1***3**

    1'**3**

    $***3**

    $'**3**

    oste"periment pur'(ases per respon)e

    #ales

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    23/27

    Treatent

    t

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    24/27

    Nae Pre/a!e Pot/a!e Pre/.iit Pot/.iit

    13 A-o!a-o!4 Fe!i7 A-o!a-o!4 F3 $%13'* ''#3** ' 1*

    $3 Ca8a!!e4 Apri! Ca8a!!e4 A3 #1#3'% )1$3'* ' 1$

    #3 C!ori8e!4 Aor C!ori8e!4A3 14')#3## $4')'3** $* #*

    %3 Co4 A!e7ander Co4 A3 "%%3(* &"13** ( 1*

    '3 6a-!an4 Marite 6a-!an4 M3 &1(3$' 14"*)3(' 1$ $*

    "3 Fide!4 +Day Fide!4 +3 )1'3$' 14$$(3** 1' $*(3 Gon,aga4 Wi!!yn Gon,aga4 W3 ''3** 11)3** 1 $

    )3 Hernando4 Eeue! Hernando4 E3 #113*% (&%3'* ' 1$

    &3 anio!a4 Miyu9i anio!a4 M3 14''(3)( $4$%$3** $# #*

    1*3 ;oa4 Gena ;oa4 G3 14$"(3"( $4*)13'* $* #*

    113 MeDo4 Roe MeDo4 R3 )(13## 14#"%3(' 1% $*

    1$3 Poduna4 F!oren-ia Poduna4 F3 14*#13$' 14%''3** 1' $*

    1#3 0antiane4 ;!oyd 0antiane4 ;3 #1(3$* )##3** % 1*

    1%3 ntong4 Phi!ip ntong4 P3 1$*3$* ""13** $ 1*

    1'3 0u8radi!4 G!ady 0u8radi!4 G3 &'#3%* 14(*&3** 1) #*

    13 oro!an4 A!!an oro!an4 A3 14#()3)* $4%%)3** 1) #*$3 Po!inar4 Ara-e!i Po!inar4 A3 14#')3"( $4$%)3** $* #*

    #3 +pina4 Nenita +pina4 N3 14(**3"( $4("13** $* #*

    %3 Canada4 ;eonita Caada4 ;3 14")13"* $4$'$3** $% #*

    '3 5uiton4 ;ho.e!yn 5uiton4 ;3 "'(3'* 14#&'3** 1* $*

    "3 Fernande,4 aie Fernande,4 3 #1131' ))(3** ' 1#

    (3 A!igato4 ;eo A!igato4;3 #'*3** ("*3** ' 1*

    )3 A8ar-a4 etony A8ar-a4 3 ##$3*) ))13** ' 1$

    &3 Mur-ia4 rene Mur-ia4 3 14#%*3** $4*($3** $* $)

    1*3 Ca8orte4 +7a!ta-ion Ca8orte4 +3 $')3"( %#*3** % "

    113 A8ine4 +don A8ine4 +3 1(%3"* "$$3** # 1*

    1$3 ;ope,4 Cherie! ;ope,4 C3 14*"(3(# 14($*3** 1' $$

    1#3 @iri,4 Ange!a @iri,4 A3 ($(3$* 14#1$3** 1$ $*

    1%3 Hipang4 ona!yn Hipang4 3 14*&'3** 14&('3** 1' $'

    1'3 Carreon4 Minda Carreon4 M3 #*13"( (&"3** ' 1$

    13 a8agat4 Yen a8agat4Y3 "&)3** "&*3** ) 11

    $3 Gautin4 +!gen Gautin4 +3 ##%3** #$%3** ' "

    #3 C!eente4 6ani-a C!eente4 63 "%13** "$'3** ) 1*

    %3 0antiane4 ;!oyd 0antiane4 ;3 '$$3** '1$3** ' (

    '3 0i8aDan4 Caren 0i8aDan4 C3 )1*3** )**3** 1* 1$

    "3 Beri,o4 Ange! Beri,o4 A3 14$'"3** 14$$)3** 1% 1"

    (3 anio!a4 Miyu9i Miyu9i4 3 ''$3** '%(3** ' (

    )3 Baynoa4 Rowena Baynoa4 R3 )113** )*$3** & 11

    &3 Paon4 6oi-ri Paon4 63 ##(3** ##$3** ' '

    1*3 0er.i!!a4 C!ari,e 0er.i!!a4 C3 )1"3** )*"3** 1* 11

    113 +!egin4 +dgie +!egin4 +3 )%13** )$"3** 1' 1%

    1$3 5uinte4 0erio 5uinte4 03 )(&3** )'&3** 1* 1*

    1#3 Buenafe4 oge! Buenafe4 3 %"*3** %'*3** ' "

    1%3 Bet!agan4 Honey!yn Bet!agan4 H3 "*$3** ')$3** 1* )

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    25/27

    1'3 Mendo,a4 F!oren-ia Mendo,a4 F3 $%#3** $##3** ' %

    13 Mag/aoiano4 +dwin Mag/aoano "#(3** "'$3** ' 1*

    $3 6oDo4 @angie 6oDo4 @3 14$$%3** 14$()3** 1) $$

    #3 Cata!!a4 Ce!ina Catana4 C3 14"*"3** 14"'"3** $' #*

    %3 0e-i8an4 Rhea 0e-i8an4 R3 14##&3** 14%113** 1) $*

    '3 Tagyaon4 Henry Tagyaan4 H3 14##%3** 14#&%3** $* $*

    "3 Ca!i8ag4 ;u-ia Ca!i8ay4 ;3 $"13** $)13** ' '(3 Tero!4 Regin Tero!4 R3 14&)$3** $4*$)3** $# #*

    )3 +todi!!o4 +te!a +todi!!o4 +3 14(")3** 14)")3** $' #*

    &3 Na.arro4 6ea Na.arro4 63 14$''3** 14$(#3** 1) $*

    1*3 Ba!a,ue!a4 F!orenda Ba!a,ue!a4 F3 14%1"3** 14%&"3** $* $%

    113 Mag8anua4 Pedrito Mag8anua4 P3 14#"(3** 14%*(3** $* $#

    1$3 Conrado4 Bethe! Conrado4 B3 14"#13** 14"&13** $* $"

    1#3 Aniue4 Ai!een Aniue4 A3 14$&(3** 14#((3** $* $*

    1%3 uaria4 Wi!freda uaria4 W3 141**3** 141&*3** 1) $$

    1'3 ?r8i,tondo4 hon r3 ?r8i,tondo4 3 14%)#3** 14')#3** $' #*

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    26/27

    Pre/a!e Pot/a!e

    A-o!a-o!4 F3 $%13'* ''#3**

    0u8radi!4 G3 &'#3%* 14(*&3**

    ntong4 P3 1$*3$* ""13**

    0antiane4 ;3 #1(3$* )##3**

    MeDo4 R3 )(13## 14#"%3('

    ;oa4 G3 14$"(3"( $4*)13'*anio!a4 M3 14''(3)( $4$%$3**

    Hernando4 E3 #113*% (&%3'*

    Gon,aga4 W3 ''3** 11)3**

    Fide!4 +3 )1'3$' 14$$(3**

    6a-!an4 M3 &1(3$' 14"*)3('

    Co4 A3 "%%3(* &"13**

    C!ori8e!4A3 14')#3## $4')'3**

    Ca8a!!e4 A3 #1#3'% )1$3'*

    Poduna4 F3 14*#13$' 14%''3**

    oro!an4 A3 14#()3)* $4%%)3**Mur-ia4 3 14#%*3** $4*($3**

    Ca8orte4 +3 $')3"( %#*3**

    A8ine4 +3 1(%3"* "$$3**

    ;ope,4 C3 14*"(3(# 14($*3**

    @iri,4 A3 ($(3$* 14#1$3**

    Hipang4 3 14*&'3** 14&('3**

    Carreon4 M3 #*13"( (&"3**

    Po!inar4 A3 14#')3"( $4$%)3**

    +pina4 N3 14(**3"( $4("13**

    Caada4 ;3 14")13"* $4$'$3**

    5uiton4 ;3 "'(3'* 14#&'3**

    Fernande,4 3 #1131' ))(3**

    A!igato4;3 #'*3** ("*3**

    A8ar-a4 3 ##$3*) ))13**

    )(3$' a8agat4Y3 "&)3** "&*3**

    ""3)* Gautin4 +3 ##%3** #$%3**

    )*31# C!eente4 63 "%13** "$'3**

    1*%3%* 0antiane4 ;3 '$$3** )##3**

    )13** 0i8aDan4 C3 )1*3** )**3**

    )&3(1 Beri,o4 A3 14$'"3** 14$$)3**

    11*3%* Miyu9i4 3 ''$3** '%(3**

    &*311 Baynoa4 R3 )113** )*$3**

    "(3%* Paon4 63 ##(3** ##$3**

    )13"* 0er.i!!a4 C3 )1"3** )*"3**

    '"3*( +!egin4 +3 )%13** )$"3**

    )(3&* 5uinte4 03 )(&3** )'&3**

    &$3** Buenafe4 3 %"*3** %'*3**

    "*3$* Bet!agan4 H3 "*$3** ')$3**

  • 7/25/2019 Statistical Treatment and Tables_SPC Research

    27/27

    %)3"* Mendo,a4 F3 $%#3** $##3**

    1$(3%* Tagyaan4 H3 14##%3** 14#&%3**

    ")3** 6oDo4 @3 14$$%3** 14$()3**

    "%3$% uaria4 W3 141**3** 141&*3**

    (%3#& ?r8i,tondo4 3 14%)#3** 14')#3**

    ""3(* Aniue4 A3 14$&(3** 14#((3**

    '$3$* Conrado4 B3 14"#13** 14"&13**)"31( Mag8anua4 P3 14#"(3** 14%*(3**

    (*3($ Ba!a,ue!a4 F3 14%1"3** 14%&"3**

    "&3($ Na.arro4 63 14$''3** 14$(#3**

    (*3)* +todi!!o4 +3 14(")3** 14)")3**

    ")3#' Tero!4 R3 14&)$3** $4*$)3**

    )13'' Ca!i8ay4 ;3 $"13** $)13**

    "%3)' 0e-i8an4 R3 14##&3** 14%113**

    "1311 Catana4 C3 14"*"3** 14"'"3**

    '&3#$ Mag/aoano4 +3 "#(3** "'$3**